[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1996

Interleukin-10 Attenuates the Release of Proinflammatory Cytokines but Depresses Splenocyte Functions in Murine Endotoxemia

Author Affiliations

From the Division of Trauma Surgery, Department of Surgery, University of Zurich (Switzerland).

Arch Surg. 1996;131(1):51-56. doi:10.1001/archsurg.1996.01430130053009
Abstract

Objective:  To determine whether interleukin (IL)-10, besides its potent anti-inflammatory properties, causes depression of splenocyte functions in a murine model of gram-negative endotoxemia.

Design:  Mice (strain C3H/HeN) were injected intravenously with 1 mg of Escherichia coli lipopolysaccharide at 15 minutes after intravenous injection of either 200 U of recombinant murine IL-10 or saline solution. Serum levels of tumor necrosis factor α, IL-6, and IL-1α were determined at 90 minutes and 12 hours after lipopolysaccharide challenge. In addition, splenocyte proliferation and lymphokine release (IL-2, IL-6, and interferon gamma) were measured.

Results:  Pretreatment with IL-10 markedly reduced (P<.05) serum levels of tumor necrosis factor α (−79%), IL-6 (−94%), and IL-1α (−69%), but it significantly inhibited splenocyte proliferation (−32%) and IL-2 (−40%), IL-6 (−49%), and interferon gamma (−54%) release of splenocytes.

Conclusions:  Interleukin-10 prevents E coli lipopolysaccharide—induced cytokinemia but dampens antigen-driven cellular immune responses. Although IL-10 protects against the detrimental effects of proinflammatory cytokines by deactivation of macrophages, its immunosuppressive effect may augment susceptibility to repeated or continuous invasion of microorganisms, as it is observed during clinical sepsis.(Arch Surg. 1996;131:51-56)

References
1.
Tracey KJ, Lowry SF.  The role of cytokine mediators in septic shock . Adv Surg . 1990;23:21-56.
2.
Lowry SF.  Cytokine mediators of immunity and inflammation . Arch Surg . 1993; 128:1235-1241.Article
3.
Fisher CJ Jr, Dhainaut JF, Opal SM, et al.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial . JAMA . 1994;271: 1836-1843.Article
4.
Fisher CJ, Opal SM, Dhainaut JF, et al.  Influence of an anti—tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis . Crit Care Med . 1993;21:318-327.Article
5.
Abraham E, Raffin TA.  Sepsis therapy trials—continued disappointment or reason for hope? JAMA . 1994;271:1876-1878.Article
6.
Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann TR.  Interleukin-10 . Annu Rev Immunol . 1993;11:165-190.Article
7.
Fiorentino DF, Zlotnik A, Mosmann TR, Howard MH, O'Garra A.  IL-10 inhibits cytokine production by activated macrophages . J Immunol . 1991;147:3815-3822.
8.
Ralph P, Nakoinz I, Sampson-Johannes A, et al.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor . J Immunol . 1992;148:808-814.
9.
Bogdan C, Vodovotz Y, Nathan C.  Macrophage deactivation by interleukin 10 . J Exp Med . 1991;174:1549-1555.Article
10.
Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J.  Biological properties of interleukin-10 . J Clin Immunol . 1992;12:239-247.Article
11.
Gerard C, Bruyns C, Marchant A, et al.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia . J Exp Med . 1993;177:547-550.Article
12.
Howard M, Muchamuel T, Andrade S, Menon S.  Interleukin 10 protects mice from lethal endotoxemia . J Exp Med . 1993;177:1205-1208.Article
13.
deWaal Malefyt R, Haanen J, Spits H, et al.  IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression . J Exp Med . 1991;174:915-924.Article
14.
Taga K, Tosato G.  IL-10 inhibits T cell proliferation and IL-2 production . J Immunol . 1992;148:1143-1148.
15.
Ding L, Shevach EM.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function . J Immunol . 1992:148: 3133-3139.
16.
Fiorentino DF, Zlotnik A, Vieira A, et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells . J Immunol . 1991;146:3444-3451.
17.
Hsu DH, Moore KW, Spits H.  Differential effects of interleukin-4 and -10 on interleukin-2–induced interferon-γ synthesis and lymphokine-activated killer activity . Int Immunol . 1992;4:563-569.Article
18.
Ertel W, Morrison MH, Ayala A, Dean RE, Chaudry IH.  Interferon-γ attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis . Surgery . 1992;111:177-187.
19.
Ertel W, Morrison MH, Ayala A, Chaudry IH.  Chloroquine attenuates hemorrhagic shock—induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release . Blood . 1991;78:1781-1788.
20.
Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH.  Anti-TNF antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression . Immunology . 1991;74:290-297.
21.
Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH.  Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis . Arch Surg . 1993;128:89-95.Article
22.
Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH.  Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production . J Surg Res . 1994;56:579-585.Article
23.
Ayala A, Lehman DL, Herdon CD, Chaudry IH.  Mechanism of enhanced susceptibility to sepsis following hemorrhage . Arch Surg . 1994;129:1172-1178.Article
24.
Silva AT, Bayston KF, Cohen J.  Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock . J Infect Dis . 1990;162:421-427.Article
25.
Zanetti G, Heumann D, Gerain J, et al.  Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice . J Immunol . 1992;148: 1890-1897.
26.
Kohler J, Heumann D, Garotta G, et al.  IFN-γ involvement in the severity of gram-negative infections in mice . J Immunol . 1993;151:916-921.
27.
Michie HR, Manogue KR, Spriggs DR, et al.  Detection of circulating tumor necrosis factor after endotoxin administration . N Engl J Med . 1988;318:1481-1486.Article
28.
Fiorentino DF, Bond MW, Mosmann TR.  Two types of mouse T helper cells: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones . J Exp Med . 1989;170:2081-2095.Article
29.
Marchant A, Bruyns C, Vandenabeele P, et al.  Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia . Eur J Immunol . 1994;24:1167-1171.Article
30.
Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J.  The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia . J Leukoc Biol . 1994;55:711-718.
31.
Ertel W, Kremer JP, Kenney J, et al.  Downregulation of proinflammatory cytokine release in whole blood from septic patients . Blood . 1995;85:1341-1347.
×